Source:http://linkedlifedata.com/resource/pubmed/id/11907110
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
2002-3-21
|
pubmed:abstractText |
Mycoplasma infection is a leading cause of pneumonia worldwide and can lead to other respiratory complications. A component of mycoplasma respiratory diseases is immunopathologic, suggesting that lymphocyte activation is a key event in the progression of these chronic inflammatory diseases. The present study delineates the changes in T cell populations and their activation after mycoplasma infection and determines their association with the pathogenesis of murine Mycoplasma respiratory disease, due to Mycoplasma pulmonis infection. Increases in T cell population numbers in lungs and lower respiratory lymph nodes were associated with the development of mycoplasma respiratory disease. Although both pulmonary Th and CD8(+) T cells increased after mycoplasma infection, there was a preferential expansion of Th cells. Mycoplasma-specific Th2 responses were dominant in lower respiratory lymph nodes, while Th1 responses predominated in spleen. However, both mycoplasma-specific Th1 and Th2 cytokine (IL-4 and IFN-gamma) responses were present in the lungs, with Th1 cell activation as a major component of the pulmonary Th cell response. Although a smaller component of the T cell response, mycoplasma-specific CD8(+) T cells were also a significant component of pulmonary lymphoid responses. In vivo depletion of CD8(+) T cells resulted in dramatically more severe pulmonary disease, while depletion of CD4(+) T cells reduced its severity, but there was no change in mycoplasma numbers in lungs after cell depletion. Thus, mycoplasma-specific Th1 and CD8(+) T cell activation in the lung plays a critical regulatory role in development of immunopathologic reactions in Mycoplasma respiratory disease.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Bacterial,
http://linkedlifedata.com/resource/pubmed/chemical/Immunodominant Epitopes,
http://linkedlifedata.com/resource/pubmed/chemical/Interferon-gamma,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-4,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0022-1767
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
168
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
3493-501
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:11907110-Animals,
pubmed-meshheading:11907110-Antibodies, Monoclonal,
pubmed-meshheading:11907110-Antigens, Bacterial,
pubmed-meshheading:11907110-CD8-Positive T-Lymphocytes,
pubmed-meshheading:11907110-Female,
pubmed-meshheading:11907110-Immunodominant Epitopes,
pubmed-meshheading:11907110-Injections, Intraperitoneal,
pubmed-meshheading:11907110-Interferon-gamma,
pubmed-meshheading:11907110-Interleukin-4,
pubmed-meshheading:11907110-Lung,
pubmed-meshheading:11907110-Lymphocyte Count,
pubmed-meshheading:11907110-Lymphocyte Depletion,
pubmed-meshheading:11907110-Mice,
pubmed-meshheading:11907110-Mice, Inbred C3H,
pubmed-meshheading:11907110-Mycoplasma,
pubmed-meshheading:11907110-Mycoplasma Infections,
pubmed-meshheading:11907110-Pneumonia,
pubmed-meshheading:11907110-RNA, Messenger,
pubmed-meshheading:11907110-Severity of Illness Index,
pubmed-meshheading:11907110-T-Lymphocyte Subsets,
pubmed-meshheading:11907110-T-Lymphocytes, Helper-Inducer
|
pubmed:year |
2002
|
pubmed:articleTitle |
Depletion of CD8+ T cells exacerbates CD4+ Th cell-associated inflammatory lesions during murine mycoplasma respiratory disease.
|
pubmed:affiliation |
Department of Molecular Biology and Immunology, University of North Texas Health Science Center, Fort Worth, TX 76107, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|